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Although pancreatic b cells are known to expand by self-renewal in postnatal life, contribution by ductal
progenitors remains vigorously debated. In a recent issue ofDevelopmental Cell, Jorge Ferrer and colleagues
report lineage tracing studies that challenge the ductal origin hypothesis (Solar et al., 2009).Reduced b cell mass is fundamental
to diabetes mellitus, which has led to
considerable interest in b cell regenera-
tion. Despite decades of investigation,
this regeneration process remains incom-
pletely understood. Self-renewal bybcells
is the dominant mechanism of b cell mass
expansion postnatally, following stimuli
such as pregnancy or toxigene-mediated
b cell ablation (Brennand et al., 2007;
Dor et al., 2004; Nir et al., 2007; Teta
et al., 2007). What remains debated is
whether b cells are formed postnatally
from cells other than preexisting b cells,
and if so, from what cell of origin?
Proposed mechanisms have included
ductal progenitors, acinar transdifferen-
tiation, circulating progenitors, and puta-
tive pancreatic stem cells (Granger and
Kushner, 2009; Pittenger et al., 2009).
The potential of ductal progenitors has
been of interest for years, and recently
Bonner-Weir and colleagues used car-
bonic anhydrase II (CAII) promoter activity
to perform lineage tracing of ductal
epithelium (Inada et al., 2008). From birth
until age 4 weeks, substantial numbers
of acinar and endocrine cells were traced
from CAII-expressing cells. Additionally,
pancreatic duct ligation (PDL)-mediated
pancreatic injury resulted in a quarter of
the b cells being marked (Inada et al.,
2008). Additional studies by Heimberg
and colleagues showed that b cell mass
doubled in the ligated portion a week after
PDL (Xu et al., 2008). PDL-activated cells
expressed neurogenin 3, a critical tran-
scription factor for islet development.
However, they were not able to trace the2 Cell Metabolism 11, January 6, 2010 ª2010lineage of ductal cells to b cells in vivo,
leaving open the possibility that other
cells could contribute to b cell mass
expansion.
Enter Ferrer and colleagues, who report
in Developmental Cell lineage tracing
studies that test the contribution of ductal
epithelium in b cell mass expansion and
regeneration (Solar et al., 2009). The
authors observe that HNF1b expression
is restricted to ductal epithelium in
embryonic pancreas and in the adults is
expressed throughout the ductal tree.
They derived Hnf1bCreER mice, which
express Cre recombinase fused to a
tamoxifen-binding domain of the estrogen
receptor driven by the Hnf1b promoter.
Hnf1bCreER mice were crossed with
Rosa26 reporter mice to perform lineage
tracing of Hnf1b promoter activity. After
tamoxifen treatment from E11.5–13.5,
labeled duct, b, a, and acinar cells were
found. These observations support the
notion that Hnf1b is expressed in multi-
potent embryonic progenitors. Lineage
tracing studies were then performed with
late embryonic and adult mice, and
tracing was observed throughout the
ductal epithelium, including centroacinar
cells. However, there was no contribution
by Hnf1b-expressing cells to acinar cells,
b cells, or other endocrine cells. Thus,
Ferrer and colleagues came to a surprising
and especially provocative conclusion:
pancreatic ductal epithelium does not
contribute to endocrine or acinar cells
postnatally.
Ferrer and colleagues further chal-
lenged the hypothesized ductal origin ofElsevier Inc.postnatal pancreatic regeneration with
PDL. This intervention provoked massive
pancreatic injury, causing reorganization
of pancreatic tissue into whorls of epithe-
lial ductal structures labeled by Hnf1b
expression. As expected, b cell mass
was doubled within a week of PDL, but
no b cells were marked. The authors
conclude that new b cells must have orig-
inated from a source other than ductal
epithelium. Additionally, the authors per-
formed b cell ablation studies with alloxan
followed by EGF and gastrin, previously
reported to stimulate islet neogenesis
from duct cells (Rooman and Bouwens,
2004). However, Ferrer and colleagues
again observed the lack of contribution
from Hnf1b-derived progenitors, even
though the b cell mass increased 9-fold.
The authors conclude that pancreatic
ductal epithelium does not contribute to
b cell growth during acute regeneration.
The results of Ferrer and colleagues
contradict earlier studies supporting a
ductal origin of b cells in postnatal life, but
there are important caveats. Hnf1bCreER
mice would ideally allow promoter lineage
tracing of ductal epithelial cells in a
sensitive and specific manner. However,
Hnf1bCreER mice are capable of only
extremely low labeling efficiency during
embryonic development (1%–2%). While
the Hnf1bCreER mice label a much larger
portion (40%) of adult ductal epithelial
cells, most duct cells are still unlabeled.
Given the rapid PDL-induced b cell mass
expansion, it is possible that some ductal
progenitors could have lower expression
ofHnf1b that was inadequate for excision.
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PreviewsAlthough their efforts to uncover Hnf1b
expression heterogeneity in the ductal
epithelium were unsuccessful, variability
cannot be definitively ruled out. The cells
that become marked could represent
a population of duct cells with a higher
activity of Hnf1b transcription or greater
accessibility to Cre recombinase.
Data supporting a duct origin for
islet cells postnatally in mice, rats, and
humans exist, but the ductal origin
hypothesis remains controversial and in
need of definitive experiments. Growth
of the exocrine pancreas from duct cells
during branching morphogenesis remains
an attractive hypothesis, which, surpris-
ingly, is unsupported by this paper. If
duct cells are not the origin of this
increase in b cell number after PDL,
what other candidates might produce so
many b cells this quickly? The demon-
strated increase in b cell replication after
PDL must account for some of the
increased b cell mass, with these repli-
cating cells being from either newly
formed or preexisting islets. If there are
nonduct precursor cells, they must exist
in reasonable numbers, but then why are
they not easier to identify?Assuming that the above caveats turn
out to be groundless, the studies by Ferrer
and colleagues considerably advance our
understanding of pancreas development.
Hnf1bCreER mice can be viewed as a
novel tool to identify components of
pancreas development. It can be con-
cluded that Hnf1b floxed duct cells do
not substantially contribute to endocrine
or acinar pancreas. In the future, we
imagine that Hnf1bCreER mice can be
applied to exclude pancreatic lineages
when searching for progenitors of b cell
expansion. Ultimately, it will be important
to confirm and expand the findings of
Ferrer and colleagues with lineage tracing
studies using additional markers that label
either ducts or other candidate precursor
cells.
In the end, the experiments by Ferrer
and colleagues challenge the duct origin
hypothesis, but the above caveats must
be addressed. If future similarly rigorous
experiments succeed in disproving the
duct cell origin, where do we look next
to explain the impressive regenerative
potential of the b cells? We anticipate
that the next few years will have many
surprises in this exciting field.Cell MetabolismREFERENCES
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Various members of the G protein-coupled receptor (GPCR) superfamily are known to modulate the release
of insulin from pancreatic b cells. Rosengren and colleagues have recently provided convincing evidence for
a role of increased expression of the a2A-adrenoceptor in b cells in the pathogenesis of type 2 diabetes.Type 2 diabetes (T2D) represents one of
the major threats to human health in the
21st century. One key feature of T2D is
that glucose fails to stimulate adequate
release of insulin from pancreatic b cells
to maintain normal blood glucose levels.For this reason, therapies targeted at
improving b cell function are predicted to
be of considerable therapeutic benefit.
The activity of pancreatic b cells is
modulated by several neurotransmitters
released from peripheral autonomicnerves (Ahre´n, 2000; Gilon and Henquin,
2001). The major neurotransmitter of
the peripheral parasympathetic nervous
system, acetylcholine, facilitates insulin
secretion from pancreatic b cells via
activation of the M3 muscarinic receptor11, January 6, 2010 ª2010 Elsevier Inc. 3
